These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9290790)

  • 21. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.
    Limquiaco JL; Wong J; Wong VW; Wong GL; Tse CH; Chan HY; Kwan KY; Lai PB; Chan HL
    J Med Virol; 2009 Feb; 81(2):224-9. PubMed ID: 19107976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
    Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
    Angus P; Locarnini S
    Antivir Ther; 2004 Apr; 9(2):145-8. PubMed ID: 15134176
    [No Abstract]   [Full Text] [Related]  

  • 24. Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation.
    Lau GK; He ML; Fong DY; Bartholomeusz A; Au WY; Lie AK; Locarnini S; Liang R
    Hepatology; 2002 Sep; 36(3):702-9. PubMed ID: 12198664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of entecavir in preventing hepatitis B recurrence after liver transplantation.
    Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Wang X; Shen CH; Luo Y; Xin TY; Wang SY; Qiu DK
    J Dig Dis; 2009 Nov; 10(4):321-7. PubMed ID: 19906113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
    Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W
    Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.
    Ben-Ari Z; Mor E; Bar-Nathan N; Shaharabani E; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2003 Mar; 35(2):609-11. PubMed ID: 12644066
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of chronic hepatitis B virus infection with the nucleoside analog lamivudine].
    Jung MC; Zachoval R; Sackmann M
    Z Gastroenterol; 1996 Dec; 34(12):827-8. PubMed ID: 9082663
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.
    Lee YC; Young KC; Su WC; Tsao CJ; Chen TY
    Haematologica; 2004 Apr; 89(4):ECR09. PubMed ID: 15075101
    [No Abstract]   [Full Text] [Related]  

  • 31. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.
    Di Marco V; Marzano A; Lampertico P; Andreone P; Santantonio T; Almasio PL; Rizzetto M; Craxì A;
    Hepatology; 2004 Oct; 40(4):883-91. PubMed ID: 15382125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention and treatment of hepatitis B virus infection after liver transplantation].
    Roche B; Samuel D
    Gastroenterol Clin Biol; 2005 Apr; 29(4):393-404. PubMed ID: 15864201
    [No Abstract]   [Full Text] [Related]  

  • 34. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation.
    Sevmis S; Aktas S; Zia HH; Atiq A; Akbas E; Selcuk H; Karakayali H; Haberal M
    Transplant Proc; 2011 Mar; 43(2):598-600. PubMed ID: 21440773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus infection and liver transplantation.
    Terrault NA; Wright TL
    Gut; 1997 May; 40(5):568-71. PubMed ID: 9203930
    [No Abstract]   [Full Text] [Related]  

  • 37. Indefinite passive immunization after liver transplantation for hepatitis B.
    Pruett T
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S88-9. PubMed ID: 12362305
    [No Abstract]   [Full Text] [Related]  

  • 38. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis.
    Lo CM; Cheung ST; Lai CL; Liu CL; Ng IO; Yuen MF; Fan ST; Wong J
    Ann Surg; 2001 Feb; 233(2):276-81. PubMed ID: 11176135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamivudine for hepatitis B in liver transplantation: a single-center experience.
    Malkan G; Cattral MS; Humar A; Al Asghar H; Greig PD; Hemming AW; Levy GA; Lilly LB
    Transplantation; 2000 Apr; 69(7):1403-7. PubMed ID: 10798762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.